Increased expression of RANTES, CC-chemokine ligand 5 (CCL5), has been reported in various kidney disorders and its inhibition might be an important mechanism for treatment of acute kidney injury, renal transplant rejection, and chronic kidney insufficiency. This evidence concerns the gene CCL5 and kidney disorder.